Patent Holder
Marina Shvetcova
RU 2119670 C1 МПК 6 G01N33/50
Abstract of RU2119670 (C1)
FIELD: cholecystic diseases. SUBSTANCE: level of malonic dialdehyde in chloroform- methanol extract of patientÄs bile is determined as nmols of dialdehyde per 1 ml of bile using reaction with thiobarbituric acid in an acidic waterless medium. Simultaneously, in the same extract, content of phospholipides in mg/ml (of bile) is determined. When ratio of malonic dialdehyde content to thiobarbituric acid content is higher than 5.0 nmol/mg, cholecystitis exacerbation is diagnosed. EFFECT: increased accuracy of the method due to avoiding effect of liver and non-lipid component concentration factor. 1 tbl, 1 ex
Abstract of RU2119670 (C1)
FIELD: cholecystic diseases. SUBSTANCE: level of malonic dialdehyde in chloroform- methanol extract of patientÄs bile is determined as nmols of dialdehyde per 1 ml of bile using reaction with thiobarbituric acid in an acidic waterless medium. Simultaneously, in the same extract, content of phospholipides in mg/ml (of bile) is determined. When ratio of malonic dialdehyde content to thiobarbituric acid content is higher than 5.0 nmol/mg, cholecystitis exacerbation is diagnosed. EFFECT: increased accuracy of the method due to avoiding effect of liver and non-lipid component concentration factor. 1 tbl, 1 ex